13D Filing: Horton Capital Management, LLC and Safeguard Scientifics Inc (SFE)

UNITED STATES

SECURITIES AND EXCHANGE
COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED
IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO

§ 240.13d-2(a)

(Amendment No.  )¹

Safeguard Scientifics, Inc.

(Name
of Issuer)

Common Stock, Par Value $0.10 Per Share

(Title of Class of Securities)

786449207

(CUSIP Number)

JOSEPH
M. MANKO, JR.

HORTON CAPITAL PARTNERS, LLC

1717
Arch Street, Suite 3920

Philadelphia,
PA 19103

(215)
399-5402

 

DARREN
C. WALLIS

MAPLEWOOD
PARTNERS, LLC

555.
E. Lancaster Avenue, Suite 520

Radnor,
PA 19087

(610)
816-6660

 

[With
a copy to]

ANDREW
FREEDMAN, ESQ.

MEAGAN
REDA, ESQ.

OLSHAN
FROME WOLOSKY LLP

1325
AVENUE OF THE AMERICAS

NEW
YORK, NY 10019

(212)
451-2300

(Name, Address and Telephone Number of Person

Authorized to Receive Notices
and Communications)

January 19,
2018

(Date of Event Which Requires
Filing of This Statement)

If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box ¨.

Note:  Schedules
filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See
§ 240.13d-7 for other parties to whom copies are to be sent.

1
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.

The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).